• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interferon beta in multiple sclerosis: predicting response at an early stage.

作者信息

Killestein Joep, Hartung Hans-Peter

机构信息

Department of Neurology, VU Medical Centre Amsterdam, The Netherlands.

出版信息

J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):616-7. doi: 10.1136/jnnp.2007.138396.

DOI:10.1136/jnnp.2007.138396
PMID:18487553
Abstract
摘要

相似文献

1
Interferon beta in multiple sclerosis: predicting response at an early stage.
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):616-7. doi: 10.1136/jnnp.2007.138396.
2
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis.磁共振成像活性和中和抗体作为多发性硬化症中干扰素β治疗反应的预测指标。
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. doi: 10.1136/jnnp.2007.130229. Epub 2007 Nov 6.
3
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing/remitting multiple sclerosis.复发缓解型多发性硬化症中中和抗体对干扰素β-1b影响的纵向分析
Mult Scler. 2004 Dec;10(6):713-4; author reply 715. doi: 10.1191/1352458504ms1107xx.
4
Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have?抗干扰素-β 中和抗体可能在治疗停止后持续存在：它们会产生什么影响？
Mult Scler. 2006 Jun;12(3):245-6. doi: 10.1191/135248506ms1284ed.
5
Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis?
Mult Scler. 2004 Apr;10(2):123-5. doi: 10.1191/1352458504ms1017ed.
6
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.评估干扰素-β-1b 治疗复发缓解型多发性硬化症长期安全性的横断面研究。
Neurology. 2010 Jun 8;74(23):1877-85. doi: 10.1212/WNL.0b013e3181e240d0.
7
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].[复发缓解型多发性硬化症患者中抗干扰素-β中和抗体的临床重要性]
Ugeskr Laeger. 2004 Oct 4;166(41):3606-9.
8
Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis.中和性及结合性抗β干扰素（IFN-β）抗体。多发性硬化症中干扰素β-1a与干扰素β-1b治疗的比较。
Eur J Neurol. 2000 Jan;7(1):27-34. doi: 10.1046/j.1468-1331.2000.00002.x.
9
[Betaferon in the treatment of multiple sclerosis: efficacy standards].
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):63-6.
10
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中中和抗体对干扰素β-1b影响的纵向分析
Mult Scler. 2004 Apr;10(2):126-38. doi: 10.1191/1352458504ms1004oa.

引用本文的文献

1
Interleukin 17F level and interferon β response in patients with multiple sclerosis.多发性硬化症患者的白细胞介素 17F 水平和干扰素β反应。
JAMA Neurol. 2013 Aug;70(8):1017-21. doi: 10.1001/jamaneurol.2013.192.